State Ledger
Company profile

ACHIEVE LIFE SCIENCES, INC. CIK 949858

Ticker
ACHV (Nasdaq)
Industry
In Vitro & In Vivo Diagnostic Substances
Headquarters
Seattle, WA 98021
Fiscal year end
2025 (FY)
Market Data
Close
$7.06
Change
-$0.35
Change %
-4.66%
Volume
69,186

ACHV · trading date Oct 12, 2026 · previous close $7.41 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$54.65M
Total assets
$41.79M
Total liabilities
$20.27M
Stockholders' equity
$21.52M
Cash & equivalents
$20.93M
Operating income
—
Operating cash flow
-$49.47M
Capital expenditures
$3.0K

Fiscal year 2025, via 10-K filed 2026-03-24. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$49.47M
Free cash flow margin
—
Liabilities / assets
48.5%
Equity / assets
51.5%
CapEx / revenue
—
Operating cash flow / net income
0.91×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$54.65M $41.79M $20.27M $21.52M
2024 — -$39.83M $38.63M $17.73M $20.90M
2023 — -$29.82M $19.37M $20.82M -$1.45M
2022 — -$42.35M $29.97M $21.67M $8.30M
2021 — -$33.15M $47.52M $19.47M $28.04M
Company Details
SIC code
2835
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-08-21
Financials filed via
Form 10-K
filed 2026-03-24

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Seattle, WA 98021
22722 29TH DR. SE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 16:01 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Washington — Public Companies